Professor Brook K. Baker
Contact Details:
Northeastern U. School of Law
Program on Human Rights and the Global Economy
400 Huntington Ave.
Boston, MA 02115 USA
(w) 001-617-373-3217
(cell) 001-617-259-0760
(fax) 001-617-373-5056
email: b.baker@neu.edu
Appointment Designation:
Northeastern U. School of Law – Professor
University of KwaZulu Natal – Honorary Research Fellow, Faculty of Law
Academic Qualifications:
BA (Harvard University) JD (Northeastern University)
Professional Qualifications:
Admitted: Massachusetts Bar
Research Interests:
International Intellectual Property Regime and Access to Medicines;
Drug Regulatory Mechanisms and Access to Medicines;
Global Health Initiatives and Health Systems;
International Trade and International Financial Institutions;
Global Health Policy;
Practice-based Learning
Recent Publications:
Brook K. Baker, The Impact of the International Monetary Fund’s Macroeconomic Policies on the AIDS Pandemic, 40 Int’l J. Health Services 347-363 (in publication 2010).
WHO Positive Synergies Civil Society Research Group, Interactions Between Global Health Initiatives and Health Systems – Evidence from Countries (2009) http://www.who.int/healthsystems/publications/MPS_civil_society_case_studies.pdf
Patents, Pricing, and Access to Essential Medicines in Developing Countries, 11 AMA J. Ethics – Virtual Mentor 527-32 (July 2009) http://virtualmentor.ama-assn.org/2009/07/pfor1-0907.html
World Health Organization Maximizing Positive Synergies Collaborative Group, An Assessment of interactions between global health initiatives and country health systems, 373 Lancet 2137-69 (June 20, 2009).
Brook K. Baker, Eva Ombaka, Viewpoint – The Danger of Drug Donations (In-Kind Contributions) To the Global Fund – Adverse Market and Therapeutic Effects, 373 Lancet 1218-21 (2009)
The Long and Tortured Road to Adequate, Sustained, and Spendable Domestic and Donor Financing for Health, April 2009 www.healthgap.org/bakeronhealthfinancing.htm <http://www.healthgap.org/bakeronhealthfinancing.htm>
Ending drug registration apartheid – taming data exclusivity and patent/registration linkage, 34 Am. J. Law & Med. 303-344 (2008)
David McCoy, Sara Bennett, Sophie Witter, Bob Pond, Brook Baker, Jeff Gow, Sudeep Chand, Tim Ensor, Barbara McPake, Gavin George, Health worker salaries and incomes in sub-Saharan Africa, 371 Lancet 675-681 (2008)
Gorik Ooms, Wim Van Damme, Brook K. Baker, Paul Zeitz, Ted Schrecker, “The ‘diagonal’ approach to Global Fund financing: a cure for the broader malaise of health systems? 4 Globalization & Health 6 (2008) http://www.globalizationandhealth.com/content/pdf/1744-8603-4-6.pdf
Drug Registration Barriers and Logjams, in Missing the Target #5: Improving AIDS Drug Access and Advancing Health Care for All, 49-58 (ITPC Dec. 2007) http://www.aidstreatmentaccess.org/itpc5th.pdf
Placing Access to Medicines on the Human Rights Agenda in The Power of Pills: Social, Ethical & Legal Issues in Drug Development, Marketing & Pricing, 239-248 (Jillian Clare Cohen, Patricia Illingsworth & Edo Schüklenk eds., 2006).
Processes and Issues for Improving Access to Medicines: Willingness and Ability to Utilize TRIPS Flexibilities in Non-Producing Countries, U.K. Dept. for Int’l Development, Health Systems Resource Centre (September 2004) http://www.iprsonline.org/resources/docs/Baker_TRIPS_Flex.pdf
Arthritic Flexibilities for Accessing Medicines, Analysis of WTO Action Regarding Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health, 14 Ind. Int’l & Comp. L. Rev. 613-715 (May 2004).
Working Paper: Analysis and Response to Recent WTO Action Regarding TRIPS Agreement and Public Health, United Nations Millennium Development Goals Project, Task Force 5: Infectious Diseases and Access to Essential Medicines (Dec. 2003).
Teaching Legal Skills in South Africa: A Transition from Cross-Cultural Collaboration to International HIV/AIDS Solidarity, 9 J. Legal Writing Inst. 145-183 (2003).